Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for antibody SC-1-induced apoptosis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10537313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alimentary Pharmacology & Therapeutics

  1999cited by this paper
• Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results.

  1998cited by this paper
• Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.

  1998cited by this paper
• Human CD14 mediates recognition and phagocytosis of apoptotic cells

  1998cited by this paper
• Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.

  1998cited by this paper
• Cell suicide for beginners

  1998cited by this paper
• Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter‐associated gastritis

  1998cited by this paper
• Caspases: enemies within.

  1998influential reference
• Caspases: the proteases of the apoptotic pathway

  1998cited by this paper
• Tumor-specific apoptosis induced by the human monoclonal antibody SC-1: a new therapeutical approach for stomach cancer.

  1998cited by this paper
• Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.

  1998cited by this paper
• Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

  1998cited by this paper
• Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.

  1997cited by this paper
• Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma

  1997influential reference
• Complement‐regulatory proteins in ovarian malignancies

  1997cited by this paper
• TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis*

  1997cited by this paper
• Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

  1996cited by this paper
• Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

  1996cited by this paper
• FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

  1996cited by this paper
• Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

  1996cited by this paper
• Parent ion scans of unseparated peptide mixtures.

  1996cited by this paper
• A rapid method for purification of monoclonal human IgM from mass culture

  1996cited by this paper
• Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.

  1995cited by this paper
• CTL in mice immunized with human mucin 1 are MHC-restricted.

  1995cited by this paper
• Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

  1995cited by this paper
• Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

  1995cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation.

  1995cited by this paper
• Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody

  1995cited by this paper
• Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.

  1994cited by this paper
• New US alternative medicine research centres

  1994cited by this paper
• Helicobacter pylori and gastric cancer.

  1994cited by this paper
• The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

  1994cited by this paper
• Error-tolerant identification of peptides in sequence databases by peptide sequence tags.

  1994cited by this paper
• Purification and characterization of the Fas-ligand that induces apoptosis

  1994cited by this paper
• Characterization of four new gastric cancer cell lines

  1993cited by this paper
• Lethal effect of the anti-Fas antibody in mice

  1993cited by this paper
• Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

  1993cited by this paper
• Helicobacter pylori and gastric cancer.

  1993cited by this paper
• A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF.

  1993cited by this paper
• A novel domain within the 55 kd TNF receptor signals cell death.

  1993cited by this paper
• Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.

  1992cited by this paper
• SC-1, a functional human monoclonal antibody against autologous stomach carcinoma cells.

  1989cited by this paper
• Decay-accelerating factor functions as a signal transducing molecule for human T cells.

  1988cited by this paper
• Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

  1987cited by this paper
• Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.

  1986cited by this paper
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

  1984cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper

• The role of B-1 cells in cancer progression and anti-tumor immunity

  2024cites this paper
• Phytogalactolipids activate humoral immunity against colorectal cancer

  2023cites this paper
• A zirconia-based column chromatography system optimized for the purification of IgM from hybridoma culture supernatants.

  2022cites this paper
• Natural Autoantibodies in Health and Disease

  2021cites this paper
• The IgM as a tool for recognition of early tumoral antigens

  2021cites this paper
• Complement and Cancer—A Dysfunctional Relationship?

  2020influential citation
• Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

  2020cites this paper
• Diagnostic Profiling of the Human Public IgM Repertoire With Scalable Mimotope Libraries

  2019cites this paper
• Is there a role for natural antibodies in rejection following transplantation?

  2019cites this paper
• IgM Natural Autoantibodies in Physiology and the Treatment of Disease.

  2018cites this paper
• A rationally designed mimotope library for profiling of the human IgM repertoire

  2018cites this paper
• Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors

  2016cites this paper
• SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS

  2016cites this paper
• Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review)

  2015cites this paper
• Monoclonal Antibodies for Cancer Immunotherapy

  2015cites this paper
• Anti‐NeuGcGM3 reactivity: a possible role of natural antibodies and B‐1 cells in tumor immunosurveillance

  2015cites this paper
• 2D immunoblots show differential response of mouse IgG and IgM antibodies to antigens of mammary carcinoma 4 T1 cells

  2014cites this paper
• Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1

  2014cites this paper
• Specificity of squamous cell carcinoma antigen (SCCA)‐IgM detection in patients with HCV infection and rheumatoid factor seropositivity

  2013cites this paper
• Does a "thiol shield" protect tumors from natural IgM antibody, and, if so, how can it be suppressed?

  2013cites this paper
• Increased expression of CD55 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

  2012cites this paper
• Naturally occurring antibodies directed against carbohydrate tumor antigens.

  2012cites this paper
• Titration of serum CEA , sFasL , CEA-IgM complexes and sFasL-IgM complexes in patients with gastric adenocarcinoma

  2011cites this paper
• Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury

  2010cites this paper
• Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15.

  2010cites this paper
• Role of complement in tumour formation : Friend or foe?

  2010cites this paper
• Autoantibodies to tumor-associated antigens as cancer biomarkers.

  2010cites this paper
• Natural human immunoglobulins in cancer immunotherapy.

  2009cites this paper
• Natural antibodies and cancer.

  2009cites this paper
• Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system.

  2008cites this paper
• Sensitization of Epithelial Cancer Cells with Human Monoclonal Antibodies

  2008cites this paper
• A new tumor-specific variant of GRP78 as target for antibody-based therapy

  2008cites this paper
• Natural monoclonal antibodies and cancer.

  2008cites this paper
• Antikörpertherapie in klinischer und präklinischer Anwendung bei gastrointestinalen Karzinomen

  2007cites this paper
• Natural antibodies and cancer.

  2007cites this paper
• The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein

  2007cites this paper
• Tumors: Too sweet to remember?

  2007cites this paper
• Recent developments in the systemic therapy of advanced gastroesophageal malignancies

  2006cites this paper
• Natural IgM antibodies: the orphaned molecules in immune surveillance.

  2006cites this paper
• The Expression and Action of Decay-Accelerating Factor (CD55) in Human Malignancies and Cancer Therapy

  2006cites this paper
• Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies.

  2006cites this paper
• Natural IgM antibodies: from parias to parvenus.

  2006cites this paper
• The "early birds": natural IgM antibodies and immune surveillance.

  2005influential citation
• Serological identification of breast cancer‐related antigens from a Saccharomyces cerevisiae surface display library

  2005cites this paper
• Death by stress: natural IgM-induced apoptosis.

  2005cites this paper
• The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo

  2005cites this paper
• PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors

  2004influential citation
• Identification and validation of cell surface antigens for antibody targeting in oncology.

  2004cites this paper
• Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation.

  2004cites this paper
• Natural IgM antibodies, the ignored weapons in tumour immunity.

  2004cites this paper
• CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1.

  2004cites this paper
• by using the human hybridoma technology, that tumour immunity is not induced by malignant cells, but instead the result of innate immunity and that natural IgM antibodies play an important role in immunosurveillance mechanisms against transformed cells in humans

  2004cites this paper
• The Many Faces of the Membrane Regulators of Complement

  2004cites this paper
• Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.

  2003cites this paper
• Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.

  2003cites this paper
• Analyse der Immunantwort nach neoadjuvanter Immuntherapie mit dem humanen monoklonalen Antikörper SC-1 beim Magenkarzinom

  2002cites this paper
• Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells

  2002cites this paper
• Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients

  2002cites this paper
• Expression of complement regulating factors in gastric cancer cells

  2002cites this paper
• Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies

  2002cites this paper
• A Novel Proliferation-Associated Variant of CFR-1 Defined by a Human Monoclonal Antibody

  2001cites this paper
• Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis

  2001cites this paper
• Regulation of the New Coexpressed CD55 (Decay-Accelerating Factor) Receptor on Stomach Carcinoma Cells Involved in Antibody SC-1–Induced Apoptosis

  2001cites this paper
• [Adjuvant immunotherapy of stomach carcinoma with antibody-induced apoptosis].

  2000cites this paper
• Substance pour l'obtention de medicaments antitumoraux hautement efficaces, et procede associe

  1999cites this paper
• Journal of Neuroinflammation Open Access Research Decay Accelerating Factor (cd55) Protects Neuronal Cells from Chemical Hypoxia-induced Injury

  year unknowncites this paper